TSX:PRNMedical Equipment
Profound Medical (TSX:PRN) Narrowing EPS Loss In Q3 2025 Tests Growth Optimism Narrative
Profound Medical (TSX:PRN) has released its FY 2025 numbers, with the latest quarter showing revenue of US$5.3 million and a basic EPS loss of US$0.26, alongside a net income loss of US$8.0 million. The company’s quarterly revenue has moved from US$2.2 million in Q2 2025 to US$5.3 million in Q3 2025, while basic EPS has ranged from a loss of US$0.52 in Q2 to a loss of US$0.26 in Q3 over the same period. For investors, the headline story is that top line growth is coming alongside pressured...